OXYGENTA PHARMACEUTICAL
Back to Income Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Operating Profit History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹-9.70 Cr | ₹-7.12 Cr | ₹147,599 Cr | ₹3.84 Cr | ₹-7.87 Cr |
What is the latest Operating Profit of OXYGENTA PHARMACEUTICAL ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹-9.70 Cr |
| Mar2024 | ₹-7.12 Cr |
| Mar2023 | ₹147,599 Cr |
| Mar2022 | ₹3.84 Cr |
| Mar2021 | ₹-7.87 Cr |
How is Operating Profit of OXYGENTA PHARMACEUTICAL Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-9.70 Cr | Negative | |
| Mar2024 | ₹-7.12 Cr | Negative | |
| Mar2023 | ₹147,599 Cr | 3,841,628.53 | |
| Mar2022 | ₹3.84 Cr | Positive | |
| Mar2021 | ₹-7.87 Cr | - | |
Compare Operating Profit of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹186.1 Cr | -14.3% | -14.5% | -42.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,062.0 Cr | 0.4% | 2.6% | NA | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,192.0 Cr | -4.5% | 0.7% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,129.0 Cr | 5% | 4.1% | 37.2% | Stock Analytics | |
| CIPLA | ₹108,513.0 Cr | -0.5% | -3.4% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,250.0 Cr | 1.2% | 10.2% | 4.8% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -14.3% |
-14.5% |
-42.2% |
| SENSEX | -1% |
-0.1% |
7.9% |
You may also like the below Video Courses